Ademan has developed a novel piece of equipment designed to monitor the gut cycle in a new and distinctive way.
Ademan has developed a novel piece of equipment designed to monitor the gut cycle in a new and distinctive way.
As part of a funding application, the founder needed to file a patent. A draft had been prepared independently, but it required significant restructuring and refinement to meet patent office requirements and accurately capture the technical innovation.
IP Asset provided the following support:
The strengthened patent submission supported Ademan in successfully securing £1.6 million in funding, directly enabling further development and commercialisation of the technology.
